- Home
- BDL vs ICCC Comparison
BDL vs ICCC Comparison
Compare BDL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- ICCC
- Stock Information
- Founded
- BDL 1959
- ICCC 1982
- Country
- BDL United States
- ICCC United States
- Employees
- BDL N/A
- ICCC N/A
- Industry
- BDL Restaurants
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- ICCC Health Care
- Exchange
- BDL Nasdaq
- ICCC Nasdaq
- Market Cap
- BDL 44.1M
- ICCC 47.4M
- IPO Year
- BDL N/A
- ICCC 1987
- Fundamental
- Price
- BDL $23.50
- ICCC $4.98
- Analyst Decision
- BDL
- ICCC
- Analyst Count
- BDL 0
- ICCC 0
- Target Price
- BDL N/A
- ICCC N/A
- AVG Volume (30 Days)
- BDL 826.0
- ICCC 17.8K
- Earning Date
- BDL 05-20-2025
- ICCC 05-14-2025
- Dividend Yield
- BDL 2.13%
- ICCC N/A
- EPS Growth
- BDL N/A
- ICCC N/A
- EPS
- BDL 1.78
- ICCC N/A
- Revenue
- BDL $193,230,000.00
- ICCC $26,493,169.00
- Revenue This Year
- BDL N/A
- ICCC N/A
- Revenue Next Year
- BDL N/A
- ICCC N/A
- P/E Ratio
- BDL $13.37
- ICCC N/A
- Revenue Growth
- BDL 8.87
- ICCC 51.63
- 52 Week Low
- BDL $23.22
- ICCC $3.34
- 52 Week High
- BDL $29.72
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- BDL 40.39
- ICCC 40.66
- Support Level
- BDL $22.70
- ICCC $5.01
- Resistance Level
- BDL $24.01
- ICCC $5.30
- Average True Range (ATR)
- BDL 0.25
- ICCC 0.21
- MACD
- BDL -0.02
- ICCC -0.05
- Stochastic Oscillator
- BDL 35.40
- ICCC 25.48
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.